Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Nonlinear Association of Serum Sodium with Urine Output in Postoperative Pediatric Cardiac Patients Receiving Furosemide: A Retrospective Study.
Pediatric cardiology·2026
Same author
3D Virtual reality assessment of right ventricle-pulmonary artery conduit dilation and coronary compression risk: a retrospective bi-center feasibility study.
Frontiers in cardiovascular medicine·2026
Same author
Integrating between cultural competence and humility: a qualitative study of Israeli pediatric cardiologists.
International journal for equity in health·2026
Related Experiment Video
Updated: Jul 8, 2026
03:23
Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Pulmonary eosinophilia.
1Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Clinical Reviews in Allergy & Immunology
|January 17, 2008
Summary
Eosinophilic pneumonia, characterized by lung tissue infiltration, impairs gas exchange. Prompt diagnosis and treatment with glucocorticoids are crucial for managing this condition.
Area of Science:
- Pulmonology
- Immunology
- Pathology
Background:
- Eosinophils infiltrating lung tissue can cause dyspnea, fever, and cough, impairing gas exchange.
- Eosinophilic pneumonia can be secondary to drugs or parasites, or primary (idiopathic).
- Acute eosinophilic pneumonia is a life-threatening condition often misdiagnosed as community-acquired pneumonia.
Purpose of the Study:
- To differentiate between acute and chronic eosinophilic pneumonia.
- To highlight diagnostic criteria and treatment strategies for eosinophilic pneumonia.
Main Methods:
- Review of clinical presentations, diagnostic findings, and treatment outcomes for acute and chronic eosinophilic pneumonia.
- Analysis of peripheral blood eosinophil counts and bronchoalveolar lavage fluid differential.
Main Results:
- Acute eosinophilic pneumonia presents with hypoxemic respiratory failure, bilateral infiltrates, and high eosinophils in bronchoalveolar fluid, often without peripheral eosinophilia.
- Chronic eosinophilic pneumonia affects middle-aged asthmatics, presenting with mild-moderate hypoxemia, peripheral eosinophilia (>1,000/mm³), and migratory infiltrates on chest X-ray.
- Both forms show >25% eosinophils in bronchoalveolar fluid.
Conclusions:
- Distinguishing acute from chronic eosinophilic pneumonia is vital for appropriate management.
- Glucocorticoids, respiratory support, and trigger avoidance are standard treatments.
- Early recognition and intervention improve patient outcomes in eosinophilic lung diseases.